{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:04:26Z","timestamp":1772017466010,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zerbini Foundation"},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ischemic cardiomyopathy and severe left ventricular dysfunction are well established to represent the main determinants of poor survival and premature death compared with preserved ventricular function. However, the role of myocardial revascularization as a therapeutic alternative is not known to improve the long-term prognosis in this group of patients. This study will investigate whether myocardial revascularization contributes to a better prognosis for patients compared with those treated with drugs alone and followed over the long term.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study will include 600 patients with coronary artery disease associated with ischemic cardiomyopathy. The surgical or drug therapy option will be randomized, and the events considered for analysis will be all-cause mortality, nonfatal infarction, unstable angina requiring additional revascularization, and stroke. The events will be analyzed according to the intent-to-treat principle. Patients with multivessel coronary disease and left ventricular ejection fraction measurements of less than 35% will be included. In addition, myocardial ischemia will be documented by myocardial scintigraphy. Markers of myocardial necrosis will be checked at admission and after the procedure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The role of myocardial revascularization (CABG) in the treatment of patients with coronary artery disease and heart failure is not clearly established. The surgical option of revascularizing the myocardium is a procedure designed to reduce the load of myocardial hibernation in patients with heart failure caused by coronary artery disease. On the other hand, the assessment of myocardial viability is frequently used to identify patients with left ventricular ischemic dysfunction in which CABG may add survival benefit. However, the effectiveness of this option is uncertain. The great difficulty in establishing the efficacy of surgical intervention is based on the understanding of viability without ischemia. Thus, this study will include only patients with viable and truly ischemic myocardium to correct this anomaly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy submitted to medical or surgical treatment: MASS-VI (HF), <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1186\/ISRCTN77449548\">ISRCTN77449548<\/jats:ext-link>, Oct 10th, 2019 (retrospectively registered).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-020-04270-w","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T12:02:50Z","timestamp":1587038570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)"],"prefix":"10.1186","volume":"21","author":[{"given":"Paulo Cury","family":"Rezende","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whady","family":"Hueb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edimar Alcides","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Vicente Serrano","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Gomes","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Expedito Eust\u00e1quio Ribeiro","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alberto Oliveira","family":"Dallan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Antonio","family":"Gaiotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibele Larrosa","family":"Garzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo","family":"Rochitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar Higa","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago Luis","family":"Scudeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Rog\u00e9rio","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Biscegli","family":"Jatene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio Franchini","family":"Ramires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Kalil","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"4270_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.CIR.68.5.939","volume":"68","author":"T Killip","year":"1983","unstructured":"Killip T, Passamani E, Davis K. Coronary Artery Surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation. 1983;68:939\u201350.","journal-title":"Circulation"},{"key":"4270_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM197709222971201","volume":"297","author":"M Murphy","year":"1977","unstructured":"Murphy M, Hultgren H, Detre K, Thomsen J, Takaro T. Participants of the Veterans Administration Cooperative Study. Treatment of chronic stable angina: a preliminary report of survival data of the randomized Veterans Administration cooperative study. N Engl J Med. 1977;297:621.","journal-title":"N Engl J Med"},{"key":"4270_CR3","first-page":"1173","volume":"2","author":"European Coronary Surgery Study Group","year":"1982","unstructured":"European Coronary Surgery Study Group. Long-term results of prospective randomized study of coronary artery bypass surgery on stable angina pectoris. Lancet. 1982;2:1173.","journal-title":"Lancet."},{"key":"4270_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1161\/01.CIR.63.6.1329","volume":"63","author":"K Detre","year":"1981","unstructured":"Detre K, Peduzzi P, Murphy M, Hultgren H, Thomsen J, Oberman A, et al. Effect of bypass surgery on survival in patients in low- and high-risk subgroups delineated by use of simple clinical variables. Circulation. 1981;63:1329\u201338.","journal-title":"Circulation."},{"key":"4270_CR5","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1161\/01.CIR.90.6.2645","volume":"90","author":"M Emond","year":"1994","unstructured":"Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman R, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645\u201358.","journal-title":"Circulation."},{"key":"4270_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199607253350401","volume":"335","author":"Bypass Angioplasty Revascularization Investigation (BARI) Investigators","year":"1996","unstructured":"Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217\u201325 [Erratum, N Engl J Med. 1997;336:147].","journal-title":"N Engl J Med"},{"key":"4270_CR7","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","volume":"360","author":"BARI 2D Study Group","year":"2009","unstructured":"BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503\u201315.","journal-title":"N Engl J Med."},{"issue":"25","key":"4270_CR8","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","volume":"367","author":"ME Farkouh","year":"2012","unstructured":"Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375\u201384.","journal-title":"N Engl J Med."},{"issue":"17","key":"4270_CR9","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","volume":"364","author":"EJ Velazquez","year":"2011","unstructured":"Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL. STICH Investigators. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607\u201316.","journal-title":"N Engl J Med"},{"key":"4270_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care."},{"issue":"6","key":"4270_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1590\/S0066-782X2008001800003","volume":"91","author":"PB Girardi","year":"2008","unstructured":"Girardi PB, Hueb W, Nogueira CR, Takiuti ME, Nakano T, Garzillo CL, Paulitsch Fda S, G\u00f3is AF, Lopes NH, Stolf NA. Comparative costs between myocardial revascularization with or without extracorporeal circulation. Arq Bras Cardiol. 2008;91(6):340\u20136.","journal-title":"Arq Bras Cardiol."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04270-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-04270-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04270-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T13:05:02Z","timestamp":1627045502000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04270-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4270"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04270-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The \u201cMASS VI-(HF)\u201d research protocol was developed in accordance with the principles of the Declaration of Helsinki and according to the laws and regulations of our country. The Ethics Committee of the Heart Institute of the Hospital das Cl\u00ednicas of the Medical School of the University of S\u00e3o Paulo approved the study protocol. The principal investigator has and will continue to obtain written informed consent from study participants. These consents are available from the corresponding author on request. On the consent form, participants will be asked if they agree to the use of their data should they choose to withdraw from the trial. Participants will also be asked for permission for the research team to share relevant data with people from the Universities taking part in the research or from regulatory authorities, where relevant. Patients were informed that they will be randomized to surgery with extracorporeal circulation or drug treatment.All data collected during the course of the research will be kept strictly confidential and only accessed by members of the trial team. Participants will be allocated an individual trial identification number. All data will be stored in a secure database, accessible only to the Trial Steering Committee. Anonymized trial data could be shared with other researchers to enable international prospective meta-analyses. Any data required to support the protocol can be supplied on request.All named authors adhere to the authorship guidelines of Trials. All authors have agreed to publication.The Project Management Group will review the trial every 6\u2009months, and at any time if any other concern is observed during the study. An independent data monitoring committee will review outcomes for every 50 patients randomized in the study. The Hospital Ethics Committee will also routinely review the study every 6\u2009months and state specific recommendations as needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"337"}}